About Prebiomics
Prebiomics is a company based in Trento (Italy) founded in 2017. Prebiomics offers products and services including NGS Services and PreBiomics Implant Test. Prebiomics operates in a competitive market with competitors including Pendulum, Genome & Company, Siolta Therapeutics, Intus Bio and BioCopy, among others.
- Headquarter Trento, Italy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Prebiomics S.R.L.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$2.7 M (USD), Grant
May 01, 2023
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Prebiomics
Prebiomics offers a comprehensive portfolio of products and services, including NGS Services and PreBiomics Implant Test.
Provides DNA extraction, sequencing, and bioinformatics for microbial insights.
Test for preventing and treating dental implant diseases.
People of Prebiomics
Unlock access to complete
Unlock access to complete
Funding Insights of Prebiomics
Investors in Prebiomics
Prebiomics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Prebiomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Prebiomics
Investment portfolio details for Prebiomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Prebiomics
Detailed financials for Prebiomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Prebiomics Comparisons
Peer comparison for Prebiomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Prebiomics
Prebiomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pendulum, Genome & Company, Siolta Therapeutics, Intus Bio and BioCopy, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pendulum is focused on developing advanced probiotic solutions.
|
|
| Locked | Locked | Locked |
Microbiome-based immuno-oncology drugs are developed using proprietary technology.
|
|
| Locked | Locked | Locked |
Microbiome therapeutics are provided for treating chronic inflammatory diseases.
|
|
| Locked | Locked | Locked |
Sequencing technology is developed for microbiome testing and pathogen identification.
|
|
| Locked | Locked | Locked |
Developer of immunotherapies for tumor and autoimmune diseases
|
|
| Locked | Locked | Locked |
Delivers comprehensive genome sequencing solutions for microbial analysis.
|
Detailed competitors of Prebiomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Prebiomics
Complete news archive for Prebiomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prebiomics
Prebiomics was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Prebiomics is headquartered in Trento, Italy. It is registered at Trento, Trentino-alto Adige, Italy.
Paolo Ghensi is the current CEO of Prebiomics.
Prebiomics was founded in 2017 in Trento, Italy, within the biotechnology sector focused on metagenomics. Technologies for developing kits aimed at oral microbiome analysis are offered, including a sampling kit for plaque collection. Reports on microbiome composition are provided to assist in early detection of oral diseases. Flagship computational techniques utilizing artificial intelligence are employed for identifying potential clinical scenarios related to oral health.
Prebiomics's top competitors include Pendulum, Genome & Company and Siolta Therapeutics.
Prebiomics offers NGS Services and PreBiomics Implant Test.
Prebiomics has 1 investor. Key investors include European Union.